SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 17199
 
  
 
C07K PEPTIDES 5680
 
  
 
C07D HETEROCYCLIC COMPOUNDS 51111
 
  
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 37130
 
  
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 33173
 
  
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 3095
 
  
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 2376
 
  
 
C12P FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 1782
 
  
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 1679
 
  
 
C07C ACYCLIC OR CARBOCYCLIC COMPOUNDS 11127

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2017/0175,200 USE OF DOUBLE-STRANDED DNA IN EXOSOMES: A NOVEL BIOMARKER IN CANCER DETECTIONApr 01, 15Jun 22, 17[C12Q]
2017/0066,712 NOVEL MOLECULES THAT SELECTIVELY INHIBIT HISTONE DEACETYLASE 6 RELATIVE TO HISTONE DEACETYLASENov 18, 16Mar 09, 17[C07D, C07C]
2017/0038,384 TREATMENT OF TUMORS EXPRESSING MUTANT P53Jan 08, 15Feb 09, 17[A61K, C12Q, G01N, C07K]
2017/0029,525 ANTIBODIES TO HUMAN B7X FOR TREATMENT OF METASTATIC CANCERAug 31, 16Feb 02, 17[A61K, C07K]
2017/0014,391 SGK1 INHIBITORS FOR TREATMENT OF PROSTATE CANCERDec 11, 14Jan 19, 17[A61K, C12N, C07K]
2016/0368,948 IMMUNOGENIC WT-1 PEPTIDES AND METHODS OF USE THEREOFJan 14, 16Dec 22, 16[A61K, C07K]
2016/0289,261 GLUCOCORTICOID INHIBITORS FOR TREATMENT OF PROSTATE CANCERDec 11, 14Oct 06, 16[A61K, C07J]
2016/0271,086 METHODS AND COMPOSITIONS FOR INDUCING REGULATORY T-CELL GENERATIONOct 31, 14Sep 22, 16[A61K, G01N]
2016/0263,196 HEMATOPOIETIC RECOVERY FROM RADIATION INJURYNov 03, 14Sep 15, 16[A61K]
2016/0228,589 METHODS AND COMPOSITIONS FOR IMAGING DISORDERS USING POLYSPECIFIC AGENTSSep 18, 14Aug 11, 16[A61K]

View all Publication..

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9782386 CDC7 kinase inhibitors and uses thereofNov 11, 16Oct 10, 17[A61K, A61N]
9725457 6-amido derivatives of 4, 5-a epoxymorphinans for the treatment of painMay 19, 14Aug 08, 17[A61K, C07D, G01N]
9718850 Triterpene saponins, methods of synthesis and uses thereofSep 24, 14Aug 01, 17[C07H, A61K]
9701755 Membrane transporter NaPi2b (SCL34A2) epitope for antibody therapy, antibodies directed thereto, and target for cancer therapyApr 22, 15Jul 11, 17[A61K, G01N, C07K]
9629927 Single wall nanotube constructs and uses thereofSep 23, 13Apr 25, 17[A61K, C01B, B82Y]
9625456 Fluorescent silica-based nanoparticlesJul 02, 10Apr 18, 17[A61K, B82Y, G01N]
9598466 Glycopeptide constructs and uses thereofJul 13, 09Mar 21, 17[A61K, C07K]
9592238 Anti-ceramide monoclonal antibody 2A2Aug 23, 13Mar 14, 17[A61K, C07K]
9572875 Polyvalent conjugate vaccine for cancerOct 01, 15Feb 21, 17[A61K]
9562019 Substituted pyridazines as EGFR and/or KRAS inhibitorsDec 21, 07Feb 07, 17[C07D]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2017/0273,987 Methods for Treating GI Syndrome and Graft versus Host DiseaseAbandonedFeb 20, 17Sep 28, 17[A61K, C07K]
2016/0272,697 Neutralizing Antibodies to Nipah and Hendra VirusAbandonedApr 30, 12Sep 22, 16[C07K]
2016/0082,137 Clinical Multimodality-Tools for Pre-And Intraoperative Insulinoma DiagnosticsAbandonedJul 25, 14Mar 24, 16[A61K]
2016/0052,955 METHYLTRANSFERASE INHIBITORS FOR TREATING CANCERSAbandonedApr 15, 14Feb 25, 16[C07H]
2015/0313,922 COMPOSITIONS AND METHODS FOR THE TREATMENT OF CANCERS ASSOCIATED WITH A DEFICIENCY IN THE MRE11/RAD50/NBS1 DNA DAMAGE REPAIR COMPLEXAbandonedNov 27, 13Nov 05, 15[A61K, G01N, A61N]
2015/0299,278 CANCER-SPECIFIC SUICIDE GENE FOR CELL-BASED AND GENE THERAPYAbandonedJan 11, 13Oct 22, 15[A61K, C07K]
2015/0273,011 TOPICAL CORNEAL ANALGESIA USING NEUROTENSIN RECEPTOR AGONISTS AND SYNERGISTIC NEUROTENSIN COMBINATIONS WITHOUT DELAYING WOUND HEALINGAbandonedOct 10, 14Oct 01, 15[A61K]
2015/0167,084 Quantitative Assessment of Human T-Cell Repertoire Recovery After Allogeneic Hematopoietic Stem Cell TransplantationAbandonedJul 03, 13Jun 18, 15[C12Q]
2015/0030,583 Methods of Treating Serosal CancerAbandonedMar 30, 12Jan 29, 15[A61K, G01N, A61N]
2014/0228,293 PARATHYROID HORMONE ANALOGS, COMPOSITIONS AND USES THEREOFAbandonedMar 01, 12Aug 14, 14[C07K]
2014/0161,814 USES OF MONOCLONAL ANTIBODY 8H9AbandonedAug 05, 13Jun 12, 14[C07K]
2014/0113,286 Epigenomic Markers of Cancer MetastasisAbandonedDec 21, 11Apr 24, 14[C12Q]
2014/0065,141 CSF-1R INHIBITORS FOR TREATMENT OF BRAIN TUMORSAbandonedMay 04, 12Mar 06, 14[A61K]
2014/0031,368 SELECTIVE HDAC INHIBITORSAbandonedJul 08, 13Jan 30, 14[C07D, C07C]
8633170 Therapy-enhancing glucanExpiredAug 11, 10Jan 21, 14[A61K, C08B]
2013/0338,092 COMPOUNDS AND METHODS FOR TARGETING LEUKEMIC STEM CELLSAbandonedAug 16, 13Dec 19, 13[A61K, G01N]
2013/0323,774 HOMOGENOUS AND FULLY GLYCOSYLATED HUMAN ERYTHROPOIETINAbandonedApr 30, 13Dec 05, 13[G01N, C07K]
2013/0324,520 RXRG MODULATORS FOR THE TREATMENT OF CANCERAbandonedFeb 14, 12Dec 05, 13[A61K]
2013/0303,383 METHODS AND APPARATUS FOR PREDICTING PROTEIN STRUCTUREAbandonedMay 09, 13Nov 14, 13[G06F]
2013/0303,387 METHODS AND APPARATUS FOR PREDICTING PROTEIN STRUCTUREAbandonedMay 09, 13Nov 14, 13[G06F]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.